- Home
- LMB vs YDES Comparison
LMB vs YDES Comparison
Compare LMB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMB
- YDES
- Stock Information
- Founded
- LMB 1901
- YDES 2013
- Country
- LMB United States
- YDES Taiwan
- Employees
- LMB N/A
- YDES N/A
- Industry
- LMB Engineering & Construction
- YDES
- Sector
- LMB Consumer Discretionary
- YDES
- Exchange
- LMB Nasdaq
- YDES Nasdaq
- Market Cap
- LMB 1.2B
- YDES 1.1B
- IPO Year
- LMB 2014
- YDES N/A
- Fundamental
- Price
- LMB $89.97
- YDES $18.00
- Analyst Decision
- LMB Strong Buy
- YDES
- Analyst Count
- LMB 3
- YDES 0
- Target Price
- LMB $140.67
- YDES N/A
- AVG Volume (30 Days)
- LMB 242.0K
- YDES 103.6K
- Earning Date
- LMB 11-04-2025
- YDES 09-30-2025
- Dividend Yield
- LMB N/A
- YDES N/A
- EPS Growth
- LMB 35.95
- YDES N/A
- EPS
- LMB 2.92
- YDES N/A
- Revenue
- LMB $552,919,000.00
- YDES $510,360.00
- Revenue This Year
- LMB $28.57
- YDES N/A
- Revenue Next Year
- LMB $14.48
- YDES N/A
- P/E Ratio
- LMB $31.00
- YDES N/A
- Revenue Growth
- LMB 8.06
- YDES 45.76
- 52 Week Low
- LMB $63.02
- YDES $5.30
- 52 Week High
- LMB $154.05
- YDES $25.00
- Technical
- Relative Strength Index (RSI)
- LMB 35.27
- YDES N/A
- Support Level
- LMB $87.55
- YDES N/A
- Resistance Level
- LMB $98.07
- YDES N/A
- Average True Range (ATR)
- LMB 4.55
- YDES 0.00
- MACD
- LMB 0.01
- YDES 0.00
- Stochastic Oscillator
- LMB 13.47
- YDES 0.00
About LMB Limbach Holdings Inc.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.